Genotyping FcɣRs Genes of HIV-1 Patients "Progressor": Correlation With the Changing Profile of the Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

230 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-16

Study Completion Date

2020-02-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This non-interventional study aims to determine whether there is a correlation between the Fc receptor polymorphism (FcR) and the course of the disease following HIV infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment

NCT02334943

Immune Deficiency HIV-related Gut Disease - Cause Unknown Activation of Latent Virus +1 more

COMPLETED NA

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

NCT07146529

HIV Seropositivity HIV Drug Resistance HIV Infections

NOT_YET_RECRUITING

Acute HIV Infection Observational Study

NCT00296660

HIV Infections

COMPLETED

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

NCT00107029

HIV Infection

COMPLETED

A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations

NCT00001681

HIV Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 or older,
* Patient affiliated to a social security scheme,
* Informed consent dated and signed by the investigating physician the patient,
* Patients infected with HIV-1 having progressed in clinical (stage C) or biologically (CD4 nadir \<350 / mm3 and viral load\> 10,000 copies / ml)

Exclusion Criteria

* Impossibility of giving the subject informed information (subject in an emergency situation, difficulty in understanding the subject, ...)
* Subject under safeguard of justice,
* Subject under tutelage or under curatorship,

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No